Chemours Company
(CC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 619,000 | 1,353,000 | 1,807,000 | 1,447,000 | 945,000 |
| Receivables | 896,000 | 792,000 | 610,000 | 846,000 | 890,000 |
| Inventories | 1,368,000 | 1,391,000 | 1,352,000 | 1,314,000 | 1,446,000 |
| Other current assets | 0 | 0 | 0 | 0 | 29,000 |
| TOTAL | $2,937,000 | $3,597,000 | $3,835,000 | $3,683,000 | $3,374,000 |
| Non-Current Assets | |||||
| PPE Net | 3,157,000 | 3,209,000 | 3,216,000 | 3,119,000 | 3,190,000 |
| Investments And Advances | 169,000 | 165,000 | 158,000 | 192,000 | 189,000 |
| Intangibles | 105,000 | 105,000 | 105,000 | 107,000 | 110,000 |
| Other Non-Current Assets | 881,000 | 902,000 | 937,000 | 847,000 | 797,000 |
| TOTAL | $4,312,000 | $4,381,000 | $4,416,000 | $4,265,000 | $4,286,000 |
| Total Assets | $7,249,000 | $7,978,000 | $8,251,000 | $7,948,000 | $7,660,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 37,000 | 41,000 | 51,000 | 23,000 | 25,000 |
| Accounts payable and accrued liabilities | 938,000 | 963,000 | 1,159,000 | 901,000 | 1,009,000 |
| Other current liabilities | 200,000 | 208,000 | 218,000 | 232,000 | 226,000 |
| TOTAL | $1,557,000 | $2,231,000 | $2,486,000 | $2,195,000 | $2,190,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,951,000 | 3,968,000 | 3,987,000 | 3,944,000 | 3,604,000 |
| Other Non-Current Liabilities | 975,000 | 981,000 | 995,000 | 998,000 | 998,000 |
| TOTAL | $4,967,000 | $4,993,000 | $5,026,000 | $4,996,000 | $4,660,000 |
| Total Liabilities | $6,524,000 | $7,224,000 | $7,512,000 | $7,191,000 | $6,850,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,270 | 148,895 | 148,802 | 148,438 | 148,077 |
| Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| Retained earnings | 1,828,000 | 1,797,000 | 1,782,000 | 1,845,000 | 1,864,000 |
| Other shareholders' equity | -345,000 | -272,000 | -272,000 | -313,000 | -280,000 |
| TOTAL | $725,000 | $754,000 | $739,000 | $757,000 | $810,000 |
| Total Liabilities And Equity | $7,249,000 | $7,978,000 | $8,251,000 | $7,948,000 | $7,660,000 |